167 related articles for article (PubMed ID: 16403640)
1. Novel fluorescent markers for hypoxic cells of naphthalimides with two heterocyclic side chains for bioreductive binding.
Liu Y; Xu Y; Qian X; Liu J; Shen L; Li J; Zhang Y
Bioorg Med Chem; 2006 May; 14(9):2935-41. PubMed ID: 16403640
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of novel 8-oxo-8H-cyclopenta[a]acenaphthylene-7-carbonitriles as long-wavelength fluorescent markers for hypoxic cells in solid tumor.
Liu Y; Xu Y; Qian X; Xiao Y; Liu J; Shen L; Li J; Zhang Y
Bioorg Med Chem Lett; 2006 Mar; 16(6):1562-6. PubMed ID: 16403630
[TBL] [Abstract][Full Text] [Related]
3. Novel aliphatic N-oxide of naphthalimides as fluorescent markers for hypoxic cells in solid tumor.
Yin H; Zhu W; Xu Y; Dai M; Qian X; Li Y; Liu J
Eur J Med Chem; 2011 Jul; 46(7):3030-7. PubMed ID: 21550698
[TBL] [Abstract][Full Text] [Related]
4. Bis-naphthalimides: a new class of antitumor agents.
Braña MF; Castellano JM; Morán M; Pérez de Vega MJ; Romerdahl CR; Qian XD; Bousquet P; Emling F; Schlick E; Keilhauer G
Anticancer Drug Des; 1993 Aug; 8(4):257-68. PubMed ID: 8240655
[TBL] [Abstract][Full Text] [Related]
5. Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: synthesis and biological evaluation.
Yin H; Xu Y; Qian X; Li Y; Liu J
Bioorg Med Chem Lett; 2007 Apr; 17(8):2166-70. PubMed ID: 17331719
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, antitumor evaluation and DNA photocleaving activity of novel methylthiazonaphthalimides with aminoalkyl side chains.
Li Z; Yang Q; Qian X
Bioorg Med Chem Lett; 2005 Jun; 15(12):3143-6. PubMed ID: 15876532
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of anhydride precursors of the environment-sensitive fluorophores 4-DMAP and 6-DMN.
Sainlos M; Imperiali B
Nat Protoc; 2007; 2(12):3219-25. PubMed ID: 18079722
[TBL] [Abstract][Full Text] [Related]
8. Novel thiazonaphthalimides as efficient antitumor and DNA photocleaving agents: effects of intercalation, side chains, and substituent groups.
Li Z; Yang Q; Qian X
Bioorg Med Chem; 2005 Aug; 13(16):4864-70. PubMed ID: 15925513
[TBL] [Abstract][Full Text] [Related]
9. Two-photon excited fluorescent probes for calcium based on internal charge transfer.
Dong X; Yang Y; Sun J; Liu Z; Liu BF
Chem Commun (Camb); 2009 Jul; (26):3883-5. PubMed ID: 19662240
[TBL] [Abstract][Full Text] [Related]
10. Novel nitroheterocyclic hypoxic markers for solid tumor: synthesis and biological evaluation.
Zhu W; Dai M; Xu Y; Qian X
Bioorg Med Chem; 2008 Mar; 16(6):3255-60. PubMed ID: 18160298
[TBL] [Abstract][Full Text] [Related]
11. Tools for investigating peptide-protein interactions: peptide incorporation of environment-sensitive fluorophores via on-resin derivatization.
Sainlos M; Imperiali B
Nat Protoc; 2007; 2(12):3201-9. PubMed ID: 18079720
[TBL] [Abstract][Full Text] [Related]
12. Photophysics and biological applications of the environment-sensitive fluorophore 6-N,N-dimethylamino-2,3-naphthalimide.
Vázquez ME; Blanco JB; Imperiali B
J Am Chem Soc; 2005 Feb; 127(4):1300-6. PubMed ID: 15669870
[TBL] [Abstract][Full Text] [Related]
13. 2-Nitroimidazole-tricarbocyanine conjugate as a near-infrared fluorescent probe for in vivo imaging of tumor hypoxia.
Okuda K; Okabe Y; Kadonosono T; Ueno T; Youssif BG; Kizaka-Kondoh S; Nagasawa H
Bioconjug Chem; 2012 Mar; 23(3):324-9. PubMed ID: 22335430
[TBL] [Abstract][Full Text] [Related]
14. Matrix screening of substituted N-aryl-1,8-naphthalimides reveals new dual fluorescent dyes and unusually bright pyridine derivatives.
Cao H; Chang V; Hernandez R; Heagy MD
J Org Chem; 2005 Jun; 70(13):4929-34. PubMed ID: 15960490
[TBL] [Abstract][Full Text] [Related]
15. Use of 2-nitroimidazoles as bioreductive markers for tumour hypoxia.
Hodgkiss RJ
Anticancer Drug Des; 1998 Sep; 13(6):687-702. PubMed ID: 9755725
[TBL] [Abstract][Full Text] [Related]
16. Tools for investigating peptide-protein interactions: peptide incorporation of environment-sensitive fluorophores through SPPS-based 'building block' approach.
Sainlos M; Imperiali B
Nat Protoc; 2007; 2(12):3210-8. PubMed ID: 18079721
[TBL] [Abstract][Full Text] [Related]
17. Design of a bioreductively-activated fluorescent pH probe for tumor hypoxia imaging.
Nakata E; Yukimachi Y; Kariyazono H; Im S; Abe C; Uto Y; Maezawa H; Hashimoto T; Okamoto Y; Hori H
Bioorg Med Chem; 2009 Oct; 17(19):6952-8. PubMed ID: 19736018
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of 4-[3-(2-nitro-1-imidazolyl)-propylamino]-7-trifluoromethylquinoline hydrochloride (NLTQ-1), a new bioreductive agent as a hypoxia marker by 19F-magnetic resonance spectroscopy (19F-MRS).
Papadopoulou MV; Pouremad R; Rao MK; Ji M; Bloomer WD
In Vivo; 2001; 15(5):365-71. PubMed ID: 11695231
[TBL] [Abstract][Full Text] [Related]
19. An unusual addition reaction for constructing a novel pH-controlled fluorescence switch.
Zhou C; Li Y; Zhao Y; Zhang J; Yang W; Li Y
Org Lett; 2011 Jan; 13(2):292-5. PubMed ID: 21141986
[TBL] [Abstract][Full Text] [Related]
20. Fluorescent markers for hypoxic cells. A study of novel heterocyclic compounds that undergo bio-reductive binding.
Hodgkiss RJ; Begg AC; Middleton RW; Parrick J; Stratford MR; Wardman P; Wilson GD
Biochem Pharmacol; 1991 Feb; 41(4):533-41. PubMed ID: 1705123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
